(via TheNewswire)

Vancouver, British Columbia, May 5, 2026 - TheNewswire – Genix Pharmaceuticals Corporation (TSX-V: GENX) (“Genix” or the “Company”) announces the resignation of Mr. Danny Lee as Chief Financial Officer, effective April 30, 2026, to focus on his other business obligations.

On behalf of the Genix team, we thank Mr. Lee for his valuable contributions to the Company since December 2020, and wish him continued success in his future endeavours.

The Company is pleased to announce the appointment of Ms. Raylen Tamayo as Chief Financial Officer of the Company, effective May 4, 2026. Ms. Tamayo brings over 8 years of experience in finance and accounting, primarily within publicly listed companies. She began her career as an assurance and consulting associate at a top accounting firm and has since advanced through senior finance roles across a range of sectors. Her areas of expertise include IFRS compliance, financial reporting and management, control and process streamlining, as well as advisory services for initial public offerings (IPOs) and reverse takeovers (RTOs). Ms. Tamayo currently serves as a Manager at Zeus Accounting Solutions Corp., where she also holds Controller roles for several companies. She holds a Master’s degree from the University Canada West, where she majored in Finance.

About Genix

Genix Pharmaceuticals Corporation is a highly innovative Canadian ophthalmic drugs company. The Company focusses on the research, development, manufacture, licensing and sales of novel and innovative prescription and OTC ophthalmological products which meet the growing needs of consumers worldwide and especially the aging baby boomers. The Company has several products awaiting Health Canada approval.

On Behalf of the Board of Directors,

Mr. Mahmoud S. Aziz
President, Director

Genix Pharmaceuticals Corporation

www.genixpharm.com

For more information regarding Genix Pharmaceuticals Corporation, please contact:

Paul Chow
Director

Tel: +1.604.609.6199

pchow@genixpharm.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Statements included in this announcement, including statements concerning our plans, intentions and expectations, which are not historical in nature are intended to be, and are hereby identified as, "forward‐looking statements". Forward‐looking statements may be identified by words including "anticipates", "believes", "intends", "estimates", "expects" and similar expressions. The Company cautions readers that forward‐looking statements, including without limitation those relating to the Company's future operations and business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward‐looking statements.

Copyright (c) 2026 TheNewswire - All rights reserved.